Mirum Pharmaceuticals Insider Sold Shares Worth $611,273, According to a Recent SEC Filing
Eric Bjerkholt, CFO, on July 06, 2026, sold 5,000 shares in Mirum Pharmaceuticals (MIRM) for $611,273. Following the Form 4 filing with the SEC, Bjerkholt has control over a total of 42,181 common shares of the company, with 42,181 shares held directly. SEC Filing:
Story updates
09:21:16 PM UTC
SquawkNews
Mirum Pharmaceuticals Insider Sold Shares Worth $2,445,382, According to a Recent SEC Filing
Christopher Peetz, Director, CEO, on July 06, 2026, sold 20,000 shares in Mirum Pharmaceuticals (MIRM) for $2,445,382.
Following the Form 4 filing with the SEC, Peetz has control over a total of 381,809 common shares of the company, with 194,309 shares held directly and 187,500 controlled indirectly.
SEC Filing: